Halozyme Therapeutics Inc. (RV7)
Market Closed
3 Jun, 20:00
€
56. 80
-1.9
-3.24%
€
- Market Cap
20.87 P/E Ratio
- Div Yield
15 Volume
2.74 Eps
€ 58.7
Previous Close Want to track RV7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.52 | - |
| | | 2.2 | - |
| | | 1.59 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RV7 Earnings Reports FAQ
What is the earnings per share (EPS) for RV7?
The current EPS is 2.74.
What is the company's earnings growth rate?
Halozyme Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Halozyme Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Halozyme Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RV7 at this time, as Halozyme Therapeutics Inc has no recent EPS data to calculate it.
